FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.
Benedet
J L
JL
Bender
H
H
Jones
H
H
Ngan
H Y
HY
Pecorelli
S
S
D001201:Ascites / Q000209:etiology; D001706:Biopsy; D001941:Breast Diseases / Q000175:diagnosis; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D002822:Choriocarcinoma / Q000473:pathology; D016889:Endometrial Neoplasms / Q000473:pathology; D005185:Fallopian Tube Neoplasms / Q000473:pathology; D005260:Female; D005833:Genital Neoplasms, Female / Q000145:classification / Q000473:pathology*; D006801:Humans; D006828:Hydatidiform Mole / Q000175:diagnosis; D007044:Hysterectomy; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging / Q000145:classification; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D011247:Pregnancy; D012307:Risk Factors; D014328:Trophoblastic Neoplasms / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000473:pathology; D014594:Uterine Neoplasms / Q000473:pathology / Q000628:therapy; D014625:Vaginal Neoplasms / Q000473:pathology; D014846:Vulvar Neoplasms / Q000473:pathology / Q000628:therapy; D002578:Uterine Cervical Dysplasia / Q000473:pathology